Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.
Autor: | de Jong PH, Hazes JM, Barendregt PJ, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE |
---|---|
Zdroj: | Annals of the Rheumatic Diseases; Jan2013, Vol. 72 Issue 1, p72-78, 7p |
Databáze: | Complementary Index |
Externí odkaz: |